Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “A-Thalassemia”

233 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 233 results

Early research (Phase 1)Study completedNCT01316796
What this trial is testing

Topical Sodium Nitrite for Chronic Leg Ulcers in Adult Patients With Blood Disorders

Who this might be right for
Sickle Cell AnemiaSickle Cell DiseaseChronic Hemolytic Disorders
National Heart, Lung, and Blood Institute (NHLBI) 28
Not applicableStudy completedNCT07099196
What this trial is testing

Impact of Virtual Reality on Pain and Anxiety During Intravenous Cannulation Procedures Among Thalassemia Patients in UAE.

Who this might be right for
Thalassemia, BetaThalassemiaPain+2 more
Mohammed Bin Rashid University of Medicine and Health Sciences 115
Not applicableNot Yet RecruitingNCT04310059
What this trial is testing

Effect of Folic Acid Supplementation in Pregnant Women Having Thalassaemia Trait

Who this might be right for
ThalassemiaFolic Acid Deficiency Anemia
The University of Hong Kong 270
Not applicableLooking for participantsNCT06539169
What this trial is testing

FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases

Who this might be right for
Alpha-ThalassemiaBeta-ThalassemiaAmyloidosis+14 more
xCures 1,000
Testing effectiveness (Phase 2)Study completedNCT02125877
What this trial is testing

Phase II Study to Investigate the Benefits of an Improved Deferasirox Formulation (Film-coated Tablet)

Who this might be right for
Chronic Iron Overload Due to Transfusion-dependant Anemias
Novartis Pharmaceuticals 173
Testing effectiveness (Phase 2)Study completedNCT00005934
What this trial is testing

5-Azacytidine and Phenylbutyrate to Treat Severe Thalassemia

Who this might be right for
Beta Thalassemia
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 24
Early research (Phase 1)Study completedNCT03165864
What this trial is testing

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ISIS 702843 Administered Subcutaneously to Healthy Volunteers

Who this might be right for
Thalassemia
Ionis Pharmaceuticals, Inc. 36
Early research (Phase 1)Ended earlyNCT02986698
What this trial is testing

In Utero Hematopoietic Stem Cell Transplantation for Alpha-thalassemia Major (ATM)

Who this might be right for
Alpha Thalassemia MajorHemoglobinopathy; With ThalassemiaHemoglobinopathies+6 more
University of California, San Francisco 6
Large-scale testing (Phase 3)Study completedNCT00235391
What this trial is testing

Expanded Access of Deferasirox to Patients With Congenital Disorders of Red Blood Cells and Chronic Iron Overload

Who this might be right for
ThalassemiaSickle Cell DiseaseDiamond Blackfan Anemia+1 more
Novartis Pharmaceuticals 1,683
Post-approval studies (Phase 4)WithdrawnNCT02069886
What this trial is testing

Effect of Deferasirox on Endocrine Complications in Subjects With Transfusion Dependent Thalassemia

Who this might be right for
Thalassemia (Transfusion Delendent)
Novartis Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT01044186
What this trial is testing

A Protocol to Allow Treatment With ICL670 for Patients With or at Risk of Life-threatening Complications of Transfusional Iron Overload Who Are Unable to Tolerate Other Iron Chelators Because of Documented Severe Toxicity

Who this might be right for
Transfusional Iron Overload
Novartis Pharmaceuticals 30
Post-approval studies (Phase 4)UnknownNCT06299670
What this trial is testing

Efficacy of Combination of Hdroxyurea and Thalidomide Over Either Hydroxyurea or Thalidomide Alone in the Treatment of Transfusion Dependent Thalassemia in Children: A Quasi-Randomised Clinical Trial

Who this might be right for
Transfusion-dependent Thalassemia
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh 90
Not applicableEnrolling By InvitationNCT03655223
What this trial is testing

Early Check: Expanded Screening in Newborns

Who this might be right for
Spinal Muscular AtrophyFragile X SyndromeFragile X - Premutation+182 more
RTI International 30,000
Not applicableStudy completedNCT02326597
What this trial is testing

Decision Aid for Therapeutic Options In Sickle Cell Disease

Who this might be right for
Sickle Cell DiseaseSickle Cell AnemiaHemoglobin SS+2 more
Emory University 134
Testing effectiveness (Phase 2)Study completedNCT01186419
What this trial is testing

Safety and Pharmacodynamic Study of an Oral Iron Chelator Given for 6 Months to Patients With Iron Overload

Who this might be right for
Transfusional Iron OverloadBeta-thalassemia
Shire 51
Early research (Phase 1)Ended earlyNCT04925206
What this trial is testing

A Safety and Efficacy Study Evaluating ET-01 in Subjects with Transfusion Dependent Β-Thalassaemia

Who this might be right for
Transfusion Dependent Beta-Thalassaemia
EdiGene (GuangZhou) Inc. 8
Testing effectiveness (Phase 2)Active Not RecruitingNCT05353647
What this trial is testing

A Gene Transfer Study Inducing Fetal Hemoglobin in Sickle Cell Disease (GRASP, BMT CTN 2001)

Who this might be right for
Sickle Cell Disease
David Williams 25
Not applicableStudy completedNCT07180836
What this trial is testing

Prevalence and Hematological Characteristics of Hemoglobinopathies

Who this might be right for
Hemoglobinopathies
Bacha Khan Medical College 839
Testing effectiveness (Phase 2)Looking for participantsNCT06280378
What this trial is testing

Β-Thalassemia Treatment with KL003 Cell Injection

Who this might be right for
Transfusion-dependent Beta-Thalassemia
Kanglin Biotechnology (Hangzhou) Co., Ltd. 41
Not applicableUnknownNCT03275051
What this trial is testing

Long-term Follow-up of Subjects Treated With OTL-300 for Transfusion Dependent Beta-thalassemia Study (TIGET-BTHAL)

Who this might be right for
Beta Thalassaemia
IRCCS San Raffaele 9
Load More Results